The marketing of Vytorin and Zetia raced ahead of the science. Now Schering and Merck shareholders are $22 billion poorer
Best Deal Ads :
Leave a Reply
Sponsors
check out the A Tech Swicki swicki at eurekster.com
Monthly Archives
By Month
- October 2008 (457)
- September 2008 (2371)
- August 2008 (2051)
- July 2008 (2325)
- June 2008 (2255)
- May 2008 (2160)
- April 2008 (2371)
- March 2008 (2341)
- February 2008 (2302)
- January 2008 (2527)
- December 2007 (2025)
- November 2007 (2422)
- October 2007 (2670)
- September 2007 (2155)
- August 2007 (595)
- July 2007 (13)
- June 2007 (3)
- May 2007 (1)
- March 2007 (1)
- January 2007 (954)
- December 2006 (1644)
- November 2006 (907)
- October 2006 (11)
- September 2006 (2)
- August 2006 (1)
- June 2006 (1)
- March 2005 (19)
- October 2004 (1)
- July 2004 (1)
- June 2004 (4)
Resources
